anti-HEPARIN/HEPARAN SULFATE antibody product blog
Tags: Antibody; Monoclonal Antibody; HEPARIN/HEPARAN SULFATE; anti-HEPARIN/HEPARAN SULFATE antibody;
The HEPARIN/HEPARAN SULFATE n/a (Catalog #MBS213385) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s HEPARIN/HEPARAN SULFATE can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Radioimmunoassays (RIA), Western Blot (WB).ELISA: Minimum Dilution: 1; Maximum Dilution: 10ug/ml;
Radioimmunoassays: Minimum Dilution: 1; Maximum Dilution: 10ug/ml;
Western Blotting: Minimum Dilution: 1/500; Maximum Dilution: 1/1000. Researchers should empirically determine the suitability of the HEPARIN/HEPARAN SULFATE n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse anti Heparin/Heparan sulfate, clone T320.11, recognizes the chemically related alphabeta-linked glycosaminoglycans heparin and heparan sulfate. Both heparin and heparan sulfate are composed of alternating sequences of glucosamine and uronic acid with heparin being the more heavily sulfated polymer (Gallagher & Walker, 1985).
Perservative Stabilisers: 0.1% Sodium Azide (NaN3)
Preparation: Purified IgG prepared by affinity chromatography on Protein A. Buffer Solution: Phosphate Buffered Saline
Target Species: Broad. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing HEPARIN/HEPARAN SULFATE are readily searchable from our website. Different antibodies against the same target such as HEPARIN/HEPARAN SULFATE may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.